Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2918 (LINC02918) is classified as a long non-coding RNA (lncRNA), a type of RNA transcribed from DNA but not translated into protein[1][3][7][9]. It is located on human chromosome 1 and is also known by the aliases AL357079.1 and LOC101929609[7][9]. While lincRNAs in general play important roles in regulating gene expression, chromatin remodeling, and can be involved in disease processes such as cancer, there is currently no gene-specific biological function, disease association, or therapeutic targeting information available for LINC02918 itself[1][7][11]. No known drugs, biomarkers, or safety concerns are associated with this target, and it is not currently considered a therapeutic receptor, enzyme, transporter, or similar drug target class[1][7][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2918 (LINC02918).